Utilizamos cookies para comprender de qué manera utiliza nuestro sitio y para mejorar su experiencia. Esto incluye personalizar el contenido y la publicidad. Para más información, Haga clic . Si continua usando nuestro sitio, consideraremos que acepta que utilicemos cookies.
DxGenco is Point-Of-Care (POC) IVD company focused on developing multi-markers for people with diabetes and tuberculosis. It provides total solutions for POC diagnostics and offers full service for developing POC products from concept through commercialization.
The Epithod616 COVID-19 Ag test kit is a vitro diagnostic (IVD) test for the qualitative detection of the nucleocapsid protein antigen in nasopharyngeal swabs from individuals produced after virus infection in the human nasopharynx. The test kit is a gold nanoparticle-based immunoassay for semi-quantitative determination with Epithod616 analyzer and can be performed by non-experts at very economical cost.
The Epithod 616 COVID-19 IgM/IgG Test Kit is intended for the semi-quantitative detection of IgM and IgG antibodies to SARS-CoV-2 in whole blood, serum, and plasma from humans with a fast test time of less than two minutes. The gold nanoparticle-based immunoassay test kit is designed for use on the Epithod 616 analyzer which ensures better accuracy and improved sensitivity in analyzing results, and eliminates the risk of undesirable misreading.
El kit Epithod 616 D-Dimer es una prueba IVD para la medición rápida y cuantitativa del producto de degradación de fibrina D-Dimer en plasma. Tiene un tiempo de prueba de menos de tres minutos y un tiempo de detección de cinco segundos.
The Epithod GA Test Kit is intended for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control.
The Epithod616 COVID-19 Ag test kit is a vitro diagnostic (IVD) test for the qualitative detection of the nucleocapsid protein antigen in nasopharyngeal swabs from individuals produced after virus infection in the human nasopharynx. The test kit is a gold nanoparticle-based immunoassay for semi-quantitative determination with Epithod616 analyzer and can be performed by non-experts at very economical cost.
El kit Epithod 616 D-Dimer es una prueba IVD para la medición rápida y cuantitativa del producto de degradación de fibrina D-Dimer en plasma. Tiene un tiempo de prueba de menos de tres minutos y un tiempo de detección de cinco segundos.
The Epithod GA Test Kit is intended for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control.
The Epithod616 COVID-19 Ag test kit is a vitro diagnostic (IVD) test for the qualitative detection of the nucleocapsid protein antigen in nasopharyngeal swabs from individuals produced after virus infection in the human nasopharynx. The test kit is a gold nanoparticle-based immunoassay for semi-quantitative determination with Epithod616 analyzer and can be performed by non-experts at very economical cost.
El Epithod 616 es un analizador semiautomático para pruebas en el punto de atención para medir HbA1c, albúmina glucosilada, PCR, hemoglobina y μ-albúmina, anticuerpo COVID-19 (IgM / IgG) y antígeno.
The MagSep magnetic particle separator offers a simple and fast way for purification, concentration and separation using magnetic particle. MagSep and customizable Superparamagnetic particles (SPMPs) can be used in various kinds of bioscience and medical experiments.
The Epithod CRP Test Kit is for In-vitro diagnostic (IVD) use to determine C-reactive protein (CRP) quantitatively from human blood and serum/plasma. It can be user to diagnosis and follow-up for patients with infectious and non-infectious inflammatory diseases.
The Epithod HbA1c Test Kit is for In-vitro diagnostic (IVD) use to determine Glycated Hemoglobin (HbA1c) quantitatively from human blood. It is useful at initial assessment and long-term monitoring of glycemic control.
The Epithod 616 Hemoglobin (Hb) Test Kit is for in-vitro diagnostic (IVD) use to determine Hemoglobin (Hb) quantitatively in whole blood from a human. It provides valuable information when the abnormal hemoglobin level is detected or when the need for further investigation in laboratory and blood donation settings.
The Epithod 616 U-Albumin Test Kit is for In-vitro diagnostic (IVD) use to determine Urine albumin (U-Albumin) quantitatively from human urine. It is useful to screen early kidney disease and response to treatment with a chronic disease like diabetes.
The Epithod 616 HbA1c Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Hemoglobin (HbA1c) quantitatively from human blood. It is useful at initial assessment and long-term monitoring of glycemic control.
The Epithod 616 COVID-19 IgM/IgG Test Kit is intended for the semi-quantitative detection of IgM and IgG antibodies to SARS-CoV-2 in whole blood, serum, and plasma from humans with a fast test time of less than two minutes. The gold nanoparticle-based immunoassay test kit is designed for use on the Epithod 616 analyzer which ensures better accuracy and improved sensitivity in analyzing results, and eliminates the risk of undesirable misreading.
El kit de prueba Epithod 616 CRP permite la determinación de la proteína C-reactiva cuantitativamente en suero/plasma o sangre total. Proporciona información para el diagnóstico, tratamiento y monitorización de enfermedades inflamatorias.
The Ep.616-R analyzer provides lab quality immunoassay results by fluorescence or imaging photometry and is customizable for various rapid test kits. Portable and user-friendly, the rapid test reader allows healthcare professionals to derive quantitative or qualitative results within minutes.